Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver...

por Ordóñez-Vázquez, Ana Luisa, Beltrán-Gall, Sofía Murúa, Pal, Shreya C., Méndez-Sánchez, Nahum
Publicado 2022

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma

por Chavez-Tapia, Norberto C, Murúa-Beltrán Gall, Sofía, Ordoñez-Vázquez, Ana Luisa, Nuño-Lambarri, Natalia, Vidal-Cevallos, Paulina, Uribe, Misael
Publicado 2022

Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients

por Ordoñez-Vázquez, Ana Luisa, Juárez-Hernández, Eva, Zuarth-Vázquez, Julia María, Ramos-Ostos, Martha Helena, Uribe, Misael, Castro-Narro, Graciela, López-Méndez, Iván
Publicado 2022